Neogenomics Inc (NEO)

Nov 15, 2024

Los Angeles Capital Management LLC Invests $1.10 Million in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Nov 15, 2024

Nov 14, 2024

T. Rowe Price Investment Management Reduces Stake in NeoGenomics Inc - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Janus Henderson Group PLC's Strategic Reduction in NeoGenomics I - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Felicia Williams Joins NeoGenomics Board of Directors - The Bakersfield Californian

Nov 14, 2024

Nov 14, 2024

NeoGenomics Appoints Former Macy's CFO Felicia Williams to Board of Directors | NEO Stock News - StockTitan

Nov 14, 2024

Nov 14, 2024

Trend Tracker for (NEO) - Stock Traders Daily

Nov 14, 2024

Nov 12, 2024

Pathological Examination Market to Grow with Leading Key - openPR

Nov 12, 2024

Nov 09, 2024

Creative Planning Purchases 7,004 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

Nov 09, 2024

Nov 08, 2024

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference - BioSpace

Nov 08, 2024

Nov 08, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Receives $19.89 Consensus Target Price from Brokerages - Defense World

Nov 08, 2024

Nov 08, 2024

NeoGenomics (NEO) Upgraded to Strong Buy: Here's What You Should Know - MSN

Nov 08, 2024

Nov 07, 2024

NeoGenomics posts $18M net loss in Q3 - Gulfshore Business

Nov 07, 2024

Nov 07, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 07, 2024

Nov 07, 2024

Earnings call: NeoGenomics sees growth with NGS and new test launches By Investing.com - Investing.com South Africa

Nov 07, 2024

Nov 07, 2024

Earnings call: NeoGenomics sees growth with NGS and new test launches - Investing.com India

Nov 07, 2024

Nov 06, 2024

NeoGenomics' (NEO) Buy Rating Reiterated at Needham & Company LLC - MarketBeat

Nov 06, 2024

Nov 06, 2024

NeoGenomics Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Nov 06, 2024

Nov 05, 2024

NeoGenomics Reports Strong Q3 2024 Growth - TipRanks

Nov 05, 2024

Nov 05, 2024

NeoGenomics (NEO) Reports Q3 Earnings: What Key Metrics Have to Say - MSN

Nov 05, 2024

Nov 05, 2024

NeoGenomics receives New York state approval for its solid tumor test - MSN

Nov 05, 2024

Nov 05, 2024

NeoGenomics: Q3 Earnings Snapshot - The Washington Post

Nov 05, 2024

Nov 05, 2024

NeoGenomics (NASDAQ:NEO) Updates FY 2024 Earnings Guidance - MarketBeat

Nov 05, 2024

Nov 05, 2024

NeoGenomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 05, 2024

Nov 05, 2024

NeoGenomics Reports Third Quarter 2024 Results - Business Wire

Nov 05, 2024

Nov 05, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 05, 2024

Nov 04, 2024

Wall Street Analysts Believe NeoGenomics (NEO) Could Rally 51.29%: Here's is How to Trade - MSN

Nov 04, 2024

Nov 03, 2024

Emerald Mutual Fund Advisers Trust Sells 314,330 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Nov 03, 2024

Nov 03, 2024

Allspring Global Investments Holdings LLC Reduces Stake in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

Nov 03, 2024

Nov 03, 2024

NeoGenomics (NEO) Set to Announce Quarterly Earnings on Tuesday - Defense World

Nov 03, 2024

Nov 02, 2024

Blue Trust Inc. Boosts Stake in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

Nov 02, 2024

Oct 23, 2024

NeoGenomics gains conditional approval for solid tumour assays in New York - Medical Device Network

Oct 23, 2024

Oct 22, 2024

NeoGenomics NGS tests gain New York State approval - Investing.com

Oct 22, 2024

Oct 22, 2024

NEONeoGenomics, Inc. Latest Stock News & Market Updates - StockTitan

Oct 22, 2024

Oct 22, 2024

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test - Business Wire

Oct 22, 2024

Oct 22, 2024

Clinical Laboratory Tests Market 2023-2031 | Latest Overview Analysis Report - InsightAce Analytic

Oct 22, 2024

Oct 17, 2024

Truist Financial Corp Sells 4,699 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

Oct 17, 2024

Oct 16, 2024

NeoGenomics (NASDAQ:NEO) Shares Down 2.5%Should You Sell? - MarketBeat

Oct 16, 2024

Oct 16, 2024

Is NeoGenomics (NASDAQ:NEO) A Risky Investment? - Simply Wall St

Oct 16, 2024

Oct 15, 2024

Neogenomics Inc. (NEO) gets rating Resumed from Craig Hallum - Knox Daily

Oct 15, 2024

Oct 15, 2024

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024 - BioSpace

Oct 15, 2024

Oct 15, 2024

Analytical Lens: Exploring Neogenomics Inc. (NEO)’s Financial Story Through Ratios - The Dwinnex

Oct 15, 2024

Oct 14, 2024

Check out these key findings about Neogenomics Inc. (NEO) - SETE News

Oct 14, 2024

Oct 13, 2024

Renaissance Technologies LLC Cuts Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Oct 13, 2024

Oct 12, 2024

(NEO) Technical Data - Stock Traders Daily

Oct 12, 2024

Oct 11, 2024

Breast Cancer Liquid Biopsy Market is expected to Double Its Size - openPR

Oct 11, 2024

Oct 11, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 11, 2024

Oct 09, 2024

NEO (Neogenomics Inc.) may reap gains as insiders became active recently - Knox Daily

Oct 09, 2024

Oct 09, 2024

Neogenomics Inc. (NEO)’s results reveal risk - US Post News

Oct 09, 2024